These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15060418)

  • 1. The effect of submaximal exercise on fibrinolysis.
    Fras Z; Keber D; Chandler WL
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):227-34. PubMed ID: 15060418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator.
    de Boer A; Kluft C; Kroon JM; Kasper FJ; Schoemaker HC; Pruis J; Breimer DD; Soons PA; Emeis JJ; Cohen AF
    Thromb Haemost; 1992 Jan; 67(1):83-7. PubMed ID: 1615490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Influence of acute hypertriglyceridemia on plasma t-PA in healthy male volunteers.
    Kemme MJ; Burggraaf J; Schoemaker RC; Cohen AF
    Thromb Res; 2001 Jul; 103(1):9-16. PubMed ID: 11434941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic response during exercise and epinephrine infusion in the same subjects.
    Chandler WL; Veith RC; Fellingham GW; Levy WC; Schwartz RS; Cerqueira MD; Kahn SE; Larson VG; Cain KC; Beard JC
    J Am Coll Cardiol; 1992 Jun; 19(7):1412-20. PubMed ID: 1593033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
    Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
    Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splanchnic extraction and clearance of tissue plasminogen activator (t-PA) after injection of recombinant t-PA (Actilyse) in resting healthy subjects is proportional to the arterial concentration.
    Jørgensen M; Tønnesen KH; Petersen KR; Jespersen J; Gram J; Vinberg N
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):331-8. PubMed ID: 12032399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
    Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exercise.
    de Boer A; Kluft C; Dooijewaard G; Kasper FJ; Kroon JM; Breimer DD; Stiekema JC; Cohen AF
    Thromb Haemost; 1992 Nov; 68(5):550-5. PubMed ID: 1280862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase.
    van Griensven JM; Burggraaf KJ; Gerloff J; Günzler WA; Beier H; Kroon R; Huisman LG; Schoemaker RC; Kluft K; Cohen AF
    Clin Pharmacol Ther; 1995 Apr; 57(4):381-9. PubMed ID: 7712665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in u-PA and t-PA increase during acute exercise: relation with exercise parameters.
    van den Burg PJ; Dooijewaard G; van Vliet M; Mosterd WL; Kluft C; Huisveld IA
    Thromb Haemost; 1994 Feb; 71(2):236-9. PubMed ID: 8191405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.
    De Boer A; Kluft C; Kasper FJ; Kroon JM; Schoemaker HC; Breimer DD; Soons PA; Cohen AF
    Br J Clin Pharmacol; 1993 Aug; 36(2):99-104. PubMed ID: 8398589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator.
    van Griensven JM; Huisman LG; Stuurman T; Dooijewaard G; Kroon R; Schoemaker RC; Kluft K; Cohen AF
    Clin Pharmacol Ther; 1996 Nov; 60(5):504-11. PubMed ID: 8941023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.
    Stein CM; Brown N; Vaughan DE; Lang CC; Wood AJ
    J Am Coll Cardiol; 1998 Jul; 32(1):117-22. PubMed ID: 9669258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of angiotensin II on fibrinolysis in healthy volunteers.
    Larsson PT; Schwieler JH; Wallén NH; Hjemdahl P
    Blood Coagul Fibrinolysis; 1999 Jan; 10(1):19-24. PubMed ID: 10070831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A kinetic model of the circulatory regulation of tissue plasminogen activator during exercise, epinephrine infusion, and endurance training.
    Chandler WL; Levy WC; Veith RC; Stratton JR
    Blood; 1993 Jun; 81(12):3293-302. PubMed ID: 8507867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans.
    Smith DT; Hoetzer GL; Greiner JJ; Stauffer BL; DeSouza CA
    J Physiol; 2003 Jan; 546(Pt 1):289-98. PubMed ID: 12509496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
    Lucore CL; Fujii S; Sobel BE
    Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant lys-plasminogen given before, but not after, recombinant tissue-type plasminogen activator markedly improves coronary thrombolysis in dogs: relationship of thrombolytic efficacy with parameters of fibrinolysis.
    Chen LY; Nichols WW; Saldeen TG; Mehta JL
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):283-9. PubMed ID: 8720429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.